SAB BIOTHERAPEUTICS Stock Price, News & Analysis

BCYPU NASDAQ

Company Description

SAB BIOTHERAPEUTICS (NASDAQ: BCYPU) is a publicly traded company.

BCYPU stock has declined 17.6% over the past year.

This page provides a comprehensive overview of BCYPU stock, including real-time price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.

Stock Performance

Chart

$—

0.00%

0.00

Last updated:

-17.6%

Performance 1 year

$0.0

Market Cap

11.9M

Shares outstanding

SAB BIOTHERAPEUTICS (BCYPU) stock. Over the past 12 months, the stock has lost 17.6%.

Latest News

View All

October 6, 2021

+0.24%

SAB Biotherapeutics to Host Virtual R&D Day on October 13, 2021

conferences

October 4, 2021

-1.17%

SAB Biotherapeutics Announces First Patient Dosed in Phase 3 NIH ACTIV-2 Trial Evaluating SAB-185 for Treatment of COVID-19

clinical trial covid-19

September 28, 2021

0.00%

SAB Biotherapeutics Appoints Russell Beyer Chief Financial Officer

management

September 24, 2021

+0.57%

SAB Biotherapeutics Announces SAB-185 Receives Positive DSMB Review and Advances to Phase 3 in NIH-Sponsored ACTIV-2 Trial for Treatment of COVID-19

clinical trial covid-19

September 22, 2021

+1.65%

SAB Biotherapeutics Awarded Additional $60.5M from BARDA and U.S. Department of Defense for Rapid Response Capability and Advancing SAB-185 for Treatment of COVID-19

covid-19

September 15, 2021

-0.10%

SAB Biotherapeutics Announces Completion of Enrollment in Phase 2a Challenge Trial of SAB-176 for the Treatment of Seasonal Influenza

clinical trial

SAB BIOTHERAPEUTICS has 10 recent news articles. Of the recent coverage, 6 articles coincided with positive price movement and 2 with negative movement. Key topics include conferences, clinical trial, covid-19, management, acquisition. View all BCYPU news →

SEC Filings

View All

No SEC filings available for BCYPU.

Financial Highlights

View Full Financials

—

Revenue (TTM)

—

Net Income (TTM)

—

Diluted EPS (TTM)

—

Operating Cash Flow

—

Net Profit Margin

—

Oper. Profit Margin

Upcoming Events

Short Interest History

Last 12 Months

Days to Cover History

Last 12 Months